In particular, Serpine2/PN-1 is up-regulated in a large number of invasive/metastatic tumors including breast, prostate, pancreatic, colorectal, oral-squamous, and testicular cancers and is required for tumor growth and malignant progression [31–35]. Here, SERPINE2 is linked to metastatic neoplasm.